New Gut-Brain Parkinson’s Disease Consortium Studies Connection Between the Gut Microbiome and Parkinson's Disease
This story comes from the Fall 2024 edition of Coming Down The Pipeline: What's new & next at the DCRI, and the people making it happen sent out on December 11, 2024. Learn more about the DCRI on their website.
More than half of patients who develop Parkinson’s Disease (PD) have a history of complaints related to the gastrointestinal (GI) system, such as chronic nausea or constipation.
Moore, Kolls, and Lutz Recipients of Research & Innovation Seed Grants
The Office of Research and Innovation has named seed grant recipients for two programs, the Duke Science & Technology SPARK fund and the Duke Science & Technology LAUNCH fund.
Moore and Sanders Selected as Scialog Fellows
Carlene Moore, PhD and Laurie Sanders, PhD, have been named Scialog: Neurobiology and Changing Ecosystems Fellows.
New Platform Targets and Represses Disease-Causing Genes
Read about Ornit Chiba-Falek, PhD's collaboration to develop a new platform that targets specific genes that can cause disease.
Duke Neurology Research Round Up, January 2024
In January, members of Duke Neurology wrote and contributed to 20 peer-reviewed journal articles. This month’s research includes an article reviewing interneuron transplantation for drug-resistant epilepsy, a study on the relationship between BMI and intracerebral hemorrhage, and a study indicating that genetic associations with longevity are stronger in females than in males.
Postdoc Spotlight: Silas Buck, PhD
Silas Buck, PhD, first fell in love with neuroscience during the earliest days of his undergraduate career, when he became fascinated with the complex biological reactions that were responsible for even his earliest lab experiments. Buck pursued this passion through graduate school, studying how dopamine neurons become vulnerable to degeneration in Parkinson’s disease.
Duke Neurology Research Round Up, November 2023
This October, members of the Duke Neurology Department contributed to 11 new peer-reviewed journal articles, advancing the fields of clinical and translational neuroscience. Highlights from the past 31 days include descriptions of a new technology that uses retinal scans to detect mild cognitive impairment, a white paper outlining challenges and opportunities for clinical trials in Alzheimer's disease, and genetic analyses that advance our understanding of the origins of Alzheimer’s disease.